Cord Blood America To Educate Nurses Nationwide on Stem Cells; Major New Program

Cord Blood America Offers Continuing Education Course to Nurses on the Value of Cord Blood Collection

LAS VEGAS, July 8, 2010 - PRNewswire-FirstCall. Cord Blood America, Inc. (OTC Bulletin Board: CBAI.ob - News) (www.cordblood-america.com) is pleased to announce that it has been approved to present "The Value of Cord Blood Collection" to registered nurses in any state and offer credit hours. Cord Blood America, Inc. is supporting the Mandatory Continuing Education Law, Act 58, by helping nurses take advantage of planned learning opportunities. This provides nurses access to education, improving their knowledge and skills in regards to stem cells, cord blood collection, and the current and future treatable therapies.

"Lifelong learning serves as the basis for specialty certification and preparation to meet the demands of an evolving health care system with stem cells leading the future of medicine," said Cord Blood America CEO and co-founder Matthew Schissler.

"We believe strongly that the more people in the medical profession learn about the live saving potential of stem cells, a biological insurance policy, the more likely they are to make the informed decision in urging patients to store their babies' umbilical cord blood stem cells at birth," said Mr. Schissler.

"Cord Blood America went through the certification process to allow its medical executives to assist in this important part of the continuing education," Mr. Schissler said. "We believe this helps advance the identity, integrity and continuity of the nursing profession and improves knowledge and skills in regards to stem cells, cord blood collection and future treatable therapies. CBAI's medical staff educating thousands of nursing professionals is a scenario that we have coveted for quite some time, and one in which we will pursue and execute with vigor. Today is a great day for CBAI."

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI.ob - News) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of diseases, including cancer, leukemia, blood and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI.ob - News), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

CONTACT:
Paul Knopick
E & E Communications
949-707-5365
pknopick@eandecommunications.com